"35573-402-30" National Drug Code (NDC)

NDC Code	35573-402-30
Package Description	1 BOTTLE in 1 CARTON (35573-402-30) > 30 TABLET, FILM COATED in 1 BOTTLE
Product NDC	35573-402
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Abacavir And Lamivudine
Non-Proprietary Name	Abacavir And Lamivudine
Dosage Form	TABLET, FILM COATED
Usage	ORAL
Start Marketing Date	20170328
End Marketing Date	20220228
Marketing Category Name	ANDA
Application Number	ANDA206151
Manufacturer	Burel Pharmaceuticals, LLC
Substance Name	ABACAVIR SULFATE; LAMIVUDINE
Strength	600; 300
Strength Unit	mg/1; mg/1
Pharmacy Classes	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]